ArticleSexual medicine2026
Clinical features and risk factors analysis of diabetes mellitus complicated with Peyronie's disease.
Article in Sexual medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The association between Diabetes Mellitus (DM) and Peyronie's disease (PD), as well as the impact of DM on PD phenotypes, remains not fully elucidated. Aim: To investigate the association between PD and DM and to assess the impact of DM on the clinical phenotype of PD. Methods: This case-control study retrospectively enrolled 136 PD patients from Department of Andrology, The First Affiliated Hospital of Henan University of Chinese Medicine (December 2019 to May 2025) as the case group. Two control groups were established concurrently: andrology patients without PD and healthy examinees. To control for confounding bias, propensity score matching (PSM) was used to balance baseline characteristics. Logistic regression analysis was employed to determine the independent association between DM and PD. Furthermore, clinical characteristics were compared between PD patients with and without DM. Outcomes: This study evaluate the correlation between DM and PD, as well as the clinical manifestations of their comorbidity. Results: ① The prevalence of DM and the proportion of related risk factors were significantly higher in the case group ( Clinical Implications: This finding suggests that clinicians should be vigilant for occult yet structurally severe PD in diabetic patients and consider implementing multidisciplinary management strategies. Strengths and Limitations: The strengths of this study lie in its relatively large sample size of PD patients within the field of andrological rare diseases, the dual-control design, and the robust PSM analysis conducted. Limitations include its retrospective, single-center design and the potential for residual confounding factors. Conclusion: DM is independently associated with PD and is linked to a distinct clinical phenotype characterized by more severe fibrosis (more plaques, greater curvature) but diminished pain perception.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.